Clinical Updates for Specialty Pharmacists on PCSK9 Inhibitor Therapy
This program presented by PTCE, with expert faculty, will enable participants to differentiate between the approved PCSK9 inhibitor therapies.
The Cardiovascular Benefits of Antihyperglycemic Medications
This webinar will highlight efficacy and safety data of antihyperglycemic therapy options so that an appropriate therapy can be selected to minimize CVD in patients with T2DM.
Specialty Pharmacy Updates on PCSK9 Inhibitor Therapy for Hypercholesterolemia
The webinar will explore the economic burden of cardiovascular complications caused by high cholesterol, criteria for a benefit from PCSK9 inhibitors, and more.
An American Journal of Managed Care Symposium: Deliberations on New and Emerging Treatments for Hyperkalemia
The panel for this activity will highlight pharmacoeconomic outcomes data and formulary decision-making strategies that can reduce the burden of hyperkalemia.